| Net Cash Provided by (Used in) Operating Activities |
$1,946,000,000 |
USD |
-16% |
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Financing Activities |
$771,000,000 |
USD |
19% |
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Investing Activities |
$964,000,000 |
USD |
20% |
Q1 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q1 2024 |
Q1 2024 |
| Common Stock, Shares, Issued |
245,640,802 |
shares |
0.3% |
Q1 2024 |
Q1 2024 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q1 2024 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$211,000,000 |
USD |
32% |
Q1 2024 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$451,000,000 |
USD |
-62% |
Q1 2024 |
Q1 2024 |
| Operating Lease, Liability, Current |
$259,000,000 |
USD |
88% |
Q1 2024 |
Q1 2024 |
| Deferred Income Tax Expense (Benefit) |
$545,000,000 |
USD |
-76% |
Q1 2024 |
Q1 2024 |
| Current Income Tax Expense (Benefit) |
$834,000,000 |
USD |
787% |
Q1 2024 |
Q1 2024 |
| Additional Paid in Capital |
$18,436,000,000 |
USD |
-1.3% |
Q1 2024 |
Q1 2024 |
| Depreciation, Depletion and Amortization |
$2,972,000,000 |
USD |
15% |
Q1 2024 |
Q1 2024 |
| Share-based Payment Arrangement, Expense |
$207,000,000 |
USD |
113% |
Q1 2024 |
Q1 2024 |
| Interest Expense |
$165,000,000 |
USD |
39% |
Q1 2024 |
Q1 2024 |